Publications by authors named "M Minier"
Article Synopsis
- - The study examined cytomegalovirus (CMV) risk factors in men who have sex with men, focusing on participants in the HIV pre-exposure prophylaxis trial IPERGAY-ANRS.
- - Of the 417 participants, 382 were already CMV positive, showing a high prevalence rate of 91.6%, and 10 new cases were identified during the study.
- - Findings suggest that having many sexual partners increases the likelihood of CMV, with shedding observed in participants who seroconverted.
Article Synopsis
- This study investigates the immune response to SARS-CoV-2 after COVID-19 infection and vaccination, focusing on anti-RBD antibodies and functional neutralizing antibodies (NAbs).
- Researchers analyzed samples from different groups, including partially and fully vaccinated individuals as well as those who had COVID-19 with or without vaccination, using advanced testing methods.
- Results showed that the post-COVID/vaccination group had the strongest immune protection, with a clear link between antibody levels and neutralization ability, and the ichroma™ test proved effective in assessing immunity.
Article Synopsis
- - The study focuses on identifying social-emotional risks in toddlers to implement preventive measures through pediatric care, engaging pediatric clinicians to develop a strategic model for screening and referrals.
- - A group of six pediatricians collaborated to identify barriers and facilitators in the implementation process, ultimately prioritizing 14 strategies for enhancing the screening process based on their feasibility and effectiveness.
- - The conclusions highlight the value of clinical partners' insights in forming effective implementation strategies, suggesting that improved engagement can lead to better outcomes in screening and addressing social-emotional risks in young children.
Article Synopsis
- A study assessed the prevalence and risk factors of Human Herpesvirus-8 (HHV-8) infection among HIV-negative men who have sex with men (MSM) taking pre-exposure prophylaxis (PrEP) in France and Canada, finding a 24% seroprevalence at the start and an incidence rate of 2.66 per 100 person-years.
- Key risk factors for seropositivity included older age, a high number of sexual partners, use of chemsex, and HSV-2 positivity.
- Among those already infected, 32% showed HHV-8 in saliva, highlighting the potential for oral transmission of the virus in this group.
In this retrospective cohort study, we analyze the early humoral and cellular response in 64 adolescents KTx recipients, after two or three doses of mRNA vaccine BNT162b2 against different variants of COVID-19. After 2 doses, 77.8% % of children with no history of infection had a positive humoral response with a median anti-S IgG level of 1107 (IQR, 593-2,658) BAU/mL.
View Article and Find Full Text PDF